A5031239681- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
- Cardiac Imaging and Diagnostics
- Venous Thromboembolism Diagnosis and Management
- Cardiac tumors and thrombi
- Cardiomyopathy and Myosin Studies
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Cardiovascular and Diving-Related Complications
- Cardiac Valve Diseases and Treatments
- Cerebrovascular and Carotid Artery Diseases
- ECG Monitoring and Analysis
- Cardiovascular Syncope and Autonomic Disorders
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Health and Mental Health
- Vascular Procedures and Complications
- Cardiovascular Disease and Adiposity
- Health Systems, Economic Evaluations, Quality of Life
- Central Venous Catheters and Hemodialysis
- Parathyroid Disorders and Treatments
- Neurological disorders and treatments
- Pericarditis and Cardiac Tamponade
- Cardiovascular Function and Risk Factors
- Microbial Inactivation Methods
St David's Medical Center
2015-2024
Texas Cardiac Arrhythmia
2015-2024
The University of Texas at Austin
2010-2016
University of Milan
2016
Albert Einstein College of Medicine
2013-2014
Akron General Medical Center
2010-2013
Ospedale dell' Angelo
2010-2013
University of Foggia
2010-2013
California Pacific Medical Center
2010-2013
Centro Cardiologico Monzino
2013
Background— Together with pulmonary veins, many extrapulmonary vein areas may be the source of initiation and maintenance atrial fibrillation. The left appendage (LAA) is an underestimated site Here, we report prevalence triggers from LAA best strategy for successful ablation. Methods Results— Nine hundred eighty-seven consecutive patients (29% paroxysmal, 71% nonparoxysmal) undergoing redo catheter ablation fibrillation were enrolled. Two sixty-six (27%) showed firing became study...
Periprocedural thromboembolic and hemorrhagic events are worrisome complications of catheter ablation for atrial fibrillation (AF). The periprocedural anticoagulation management could play a role in the incidence these complications. Although procedures performed without warfarin discontinuation seem to be associated with lower risk, no randomized study exists.This was prospective, open-label, randomized, parallel-group, multicenter assessing continuous therapy preventing after...
Background— Catheter ablation of atrial fibrillation is associated with the potential risk periprocedural stroke, which can range between 1% and 5%. We developed a prospective database to evaluate prevalence stroke over time assess whether anticoagulation strategy use open irrigation catheter have resulted in reduction this complication. Methods Results— collected data from 9 centers performing same procedure protocol. divided patients into 3 groups: an 8-mm off warfarin (group 1), irrigated...
BackgroundSilent cerebral ischemia (SCI) has been reported in 14% of cases after catheter ablation atrial fibrillation (AF) with radiofrequency (RF) energy and discontinuation warfarin before AF procedures.ObjectiveThe purpose this study was to determine whether periprocedural anticoagulation management affects the incidence SCI RF using an open irrigated catheter.MethodsConsecutive patients undergoing for without receiving heparin bolus transseptal catheterization (group I, n = 146) were...
Both atrial fibrillation (AF) and amyloidosis increase stroke risk. We evaluated the best anticoagulation strategy in AF patients with coexistent amyloidosis.
Robotic catheter navigation and ablation either with magnetic driving or electromechanical guidance have emerged in the recent years for treatment of atrial fibrillation.The aim this study was to compare our center's experience fibrillation using Hansen Medical System current manual technique terms acute chronic success, as well procedure time radiation exposure both patient operator.A total 390 consecutive patients symptomatic drug-resistant (289 males, 62 +/- 11 years) were prospectively...
Pulmonary vein (PV) antrum isolation in patients with hypertrophic cardiomyopathy and atrial fibrillation (AF) has been reported to have satisfactory results at the mid- short-term follow-up. We determined outcomes long-term follow-up of PV these patients.We enrolled 43 AF (28% paroxysmal AF). (paroxysmal AF) posterior wall complex fractionated electrogram ablation (persistent longstanding persistent were end points time index procedure for repeat procedures during first year In case...
Incomplete LAA Occlusion by WATCHMAN Device . Introduction: Transcatheter left atrial appendage (LAA) closure with the device has become one of therapeutic options in fibrillation (AF) patients who are at high risk for ischemic stroke. However, incidence and evolution incomplete occlusion during after placement not been reported. Methods Results: Fifty‐eight consecutive had undergone implant were included study. Intraprocedural, 45‐day 12‐month transesophageal echocardiogram images reviewed...
Pulmonary vein antrum isolation (PVAI) remains associated with atrial fibrillation (AF) recurrence. We administered adenosine and isoproterenol (ISP) after PVAI to uncover non-PV triggers PV reconnection, potentially increasing ablation success rate.One hundred ninety-two consecutive patients symptomatic AF presenting for were prospectively studied (group 1). Following PVAI, (18-24 mg) ISP (20-30 mcg/min) intravenously. Supplemental was performed in that induced 1A). Other subgroups included...
Hybrid versus Endocardial Ablation for LSPAF Introduction of longstanding persistent atrial fibrillation (LSPAF) is the most challenging procedure in treatment AF, either by surgical or percutaneous approach. Objective We investigated difference success and complication rates between combined epicardial endocardial catheter ablation our standard procedure. Methods Results Twenty‐four consecutive patients (group 1) with enlarged left atrium (>4.5 cm) underwent a procedure, consisting...